Product Document Searching Made Easy by 2D Code! | [TCIPracticalExample] The Mitsunobu Type SN2 Reaction Using...
Users can now ask questions to the AI chatbot by clicking the chatbot icon in the bottom-right corner of the website.
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 24003-58-5 | Product Number: Q0118
QX 314 Bromide
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 2-(2,6-Dimethylanilino)-N,N,N-triethyl-2-oxoethanaminium Bromide
- 2-[(2,6-Dimethylphenyl)amino]-N,N,N-triethyl-2-oxoethan-1-aminium Bromide
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 100MG |
₹10,500.00
|
Contact Us | 11 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | Q0118 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__2__7BrN__2O = 343.31 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Hygroscopic,Heat Sensitive |
| CAS RN | 24003-58-5 |
| Reaxys Registry Number | 3789225 |
| MDL Number | MFCD00083182 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Precipitation Titration) | min. 98.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 215 °C |
GHS
Related Laws:
Transport Information:
Application
QX 314 Bromide: A Membrane-Impermeable Sodium Channel Blocker
QX 314 bromide is a membrane-impermeable lidocaine [L0156] derivative and sodium channel blocker. QX 314 bromide has been reported to selectively block sodium channels on nociceptive neurons when delivered intracellularly through the pore of the noxious heat-sensitive TRPV1 (transient receptor potential vanilloid subfamily member 1) channel, but is ineffective when applied extracellularly.1) In addition, the combination of lidocaine (as a TRPV1 agonist) and QX-314 in an injectable formulation may be a useful adjunct for regional pain control.2,3) (The product is for research use only.)
References
- 1) Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers
- 2) The quaternary lidocaine derivative, QX-314, produces long-lasting local anesthesia in animal models in vivo
- 3) Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.